SGLT2 Inhibition with Empagliflozin Increases Circulating Provascular Progenitor Cells in People with Type 2 Diabetes Mellitus

Authors: David A. Hess, Daniella C. Terenzi, Justin Z. Trac, Adrian Quan, Tamique Mason, Mohammed Al‐Omran, Deepak L. Bhatt, Natasha Dhingra, Ori D. Rotstein, Lawrence A. Leiter, Bernard Zinman, Sandra Sabongui, Andrew T. Yan, Hwee Teoh, C. David Mazer, Kim A. Connelly, Subodh Verma - Cell Metabolism 2019 cited by 108